PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

🧠 Clinical library

Clinical Specialty Index

329 articles indexed across 20 specialties, each reviewed by a licensed pharmacist before publication.

Showing 21 from 1 topic.Sort: Newest | Oldest
PID versus MPC Algorithm Response to Unannounced Meals in Adolescents
Analysis Endocrinology / Diabetes / Obesity Hypothesis-generating Grade: Low
Lo Presti D, Scirè Calabrisotto S, Tomaselli LG, et al.
Jul 10, 2026 · Published in: Endocrine

The PID algorithm optimizes glycemic control for unannounced meals in adolescents with type 1 diabetes.

Semaglutide Improves MASH Histology in Phase 3 ESSENCE Interim
Analysis Endocrinology / Diabetes / Obesity Practice-changing Grade: High
Sanyal AJ, Newsome PN, Kliers I, et al.
Apr 30, 2025 · Published in: New England Journal of Medicine

Semaglutide shows promise in treating metabolic dysfunction-associated steatohepatitis.

Finerenone Cuts Albuminuria in Type 1 Diabetes with CKD
Analysis Endocrinology / Diabetes / Obesity Hypothesis-generating Grade: Moderate
Perkovic V, Tuttle KR, Rossing P, et al.
May 24, 2024 · Published in: New England Journal of Medicine

Semaglutide slashes kidney and heart risks in diabetes with kidney disease.

Semaglutide Cuts Cardiovascular Events in Obesity Without Diabetes
Analysis Endocrinology / Diabetes / Obesity Practice-changing Grade: High
Lincoff AM, Brown-Frandsen K, Colhoun HM, et al.
Nov 11, 2023 · Published in: New England Journal of Medicine

Semaglutide cuts heart risks in obesity without diabetes.

Semaglutide Cuts Symptoms and Weight in Obesity-Related HFpEF
Analysis Endocrinology / Diabetes / Obesity Practice-changing Grade: High
Kosiborod MN, Abildstrøm SZ, Borlaug BA, et al.
Aug 25, 2023 · Published in: New England Journal of Medicine

Semaglutide enhances function and weight loss in obese heart failure patients.

Tirzepatide Delivers Up to 21% Weight Loss in Obesity
Analysis Endocrinology / Diabetes / Obesity Practice-changing Grade: High
Jastreboff AM, Aronne LJ, Ahmad NN, et al.
Jun 4, 2022 · Published in: New England Journal of Medicine

Tirzepatide delivers unprecedented weight loss results in obesity management.